oxLDL-induced decrease in lipid order of membrane domains is inversely correlated with endothelial stiffness and network formation

American Journal of Physiology - Cell Physiology

Volumn 299, Issue 2, 2010, Pages

  Shentu, Tzu Pin ^a,b   Titushkin, Igor ^b   Singh, Dev K ^a   Gooch, Keith J ^c   Subbaiah, Papasani V ^d   Cho, Michael ^b   Levitan, Irena ^a,b  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b University of Illinois at Chicago   (United States)

^c Ohio State University   (United States)

^d UNIVERSITY OF ILLINOIS   (United States)

Author keywords

Angiogenesis; Cholesterol; Lipid packing; Sphingomyelin

Indexed keywords

7 OXOCHOLESTEROL; CHOLESTEROL; CHOLESTEROL ACYLTRANSFERASE; COLLAGEN GEL; DIOLEOYLPHOSPHATIDYLCHOLINE; METHYL BETA CYCLODEXTRIN; OXIDIZED LOW DENSITY LIPOPROTEIN; SPHINGOMYELIN; LOW DENSITY LIPOPROTEIN;

ANIMAL CELL; ARTICLE; ATOMIC FORCE MICROSCOPY; BIOMECHANICS; CELL MEMBRANE; CHOLESTEROL TRANSPORT; CONTROLLED STUDY; COW; ENDOTHELIUM CELL; ENZYME ACTIVITY; NONHUMAN; PRIORITY JOURNAL; RIGIDITY; YOUNG MODULUS; ANIMAL; ATHEROSCLEROSIS; CATTLE; CELL CULTURE; CHEMISTRY; COMPARATIVE STUDY; METABOLISM; MICROVASCULATURE; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; VASCULAR ENDOTHELIUM;

ANIMALS; ATHEROSCLEROSIS; BIOMECHANICS; CATTLE; CELLS, CULTURED; CHOLESTEROL; ENDOTHELIUM, VASCULAR; LIPOPROTEINS, LDL; MEMBRANE MICRODOMAINS; MICROVESSELS; NEOVASCULARIZATION, PATHOLOGIC;

EID: 77955878803     PISSN: 03636143     EISSN: 15221563     Source Type: Journal    
DOI: 10.1152/ajpcell.00383.2009     Document Type: Article

References (49)

1. Auge N, Maupas-Schwalm F, Elbaz M, Thiers JC, Waysbort A, Itohara S, Krell HW, Salvayre R, Negre-Salvayre A. Role for matrix metalloproteinase-2 in oxidized low-density lipoprotein-induced activation of the sphingomyelin/ ceramide pathway and smooth muscle cell proliferation. Circulation 110: 571-578, 2004. (Pubitemid 39031175)
2. Blair A, Shaul PW, Yuhanna IS, Conrad PA, Smart EJ. Oxidized low-density lipoprotein displaces endothelial nitric-oxide synthase from plasmalemmal caveolae and impairs eNOS activation. J Biol Chem 274: 32512-32519, 1999. (Pubitemid 129503858)
3. Bollinger CR, Teichgraber V, Gulbins E. Ceramide-enriched membrane domains. Biochim Biophys Acta 1746: 284-294, 2005.
4. Brown A, Dean R, Jessup W. Free and esterified oxysterol: formation during copper-oxidation of low density lipoprotein and uptake by macrophages. J Lipid Res 37: 320-335, 1996. (Pubitemid 26078950)
5. Byfield F, Aranda-Aspinoza H, Romanenko VG, Rothblat GH, Levitan I. Cholesterol depletion increases membrane stiffness of aortic endothelial cells. Biophys J 87: 3336-3343, 2004. (Pubitemid 40468588)
6. Byfield FJ, Tikku S, Rothblat GH, Gooch KJ, Levitan I. OxLDL increases endothelial stiffness, force generation and network formation. J Lipid Res 47: 715-723, 2006.
7. Cazzolato G, Avogaro P, Bittolo-Bon G. Characterization of a more electronegatively charged LDL subfraction by ion exchange hplc. Free Radic Biol Med 11: 247-253, 1991. (Pubitemid 121003920)
8. Chen F, Eriksson P, Kimura T, Herzfeld I, Valen G. Apoptosis and angiogenesis are induced in the unstable coronary atherosclerotic plaque. Coron Artery Dis 16: 191-197, 2005. (Pubitemid 40586202)
9. Chouinard JA, Grenier G, Khalil A, Vermette P. Oxidized-LDL induce morphological changes and increase stiffness of endothelial cells. Exp Cell Res 314: 3007-3016, 2008.
10. Cremesti AE, Goni FM, Kolesnick R. Role of sphingomyelinase and ceramide in modulating rafts: do biophysical properties determine biologic outcome? FEBS Lett 531: 47-53, 2002. (Pubitemid 35232783)
11. Dietrich C, Bagatolli LA, Volovyk ZN, Thompson NL, Levi M, Jacobson K, Gratton E. Lipid rafts reconstituted in model membranes. Biophys J 80: 1417-1428, 2001. (Pubitemid 32182165)
12. Evans E, Needham D. Physical properties of surfactant bilayer membranes: thermal transition, elasticity, rigidity, cohesion and colloidal interactions. J Phys Chem 91: 4219-4228, 1987.
13. Garcia-Cruset S, Carpenter KL, Guardiola F, Stein BK, Mitchinson MJ. Oxysterol profiles of normal human arteries, fatty streaks and advanced lesions. Free Radic Res 35: 31-41, 2001. (Pubitemid 32725623)
14. Gardner G, Banka CL, Roberts KA, Mullick AE, Rutledge JC. Modified LDL-mediated increases in endothelial layer permeability are attenuated with 17β-estradiol. Arterioscler Thromb Vasc Biol 19: 854-861, 1999. (Pubitemid 29177329)
15. Gaus K, Gratton E, Kable EP, Jones AS, Gelissen I, Kritharides L, Jessup W. Visualizing lipid structure and raft domains in living cells with two-photon microscopy. Proc Natl Acad Sci USA 100: 15554-15559, 2003. (Pubitemid 38021028)
16. Gaus K, Le Lay S, Balasubramanian N, Schwartz MA. Integrin-mediated adhesion regulates membrane order. J Cell Biol 174: 725-734, 2006. (Pubitemid 44306728)
17. Gaus K, Zech T, Harder T. Visualizing membrane microdomains by Laurdan 2-photon microscopy. Mol Membr Biol 23: 41-48, 2006.
18. Ghosh K, Thodeti CK, Dudley AC, Mammoto A, Klagsbrun M, Ingber DE. Tumor-derived endothelial cells exhibit aberrant Rho-mediated mechanosensing and abnormal angiogenesis in vitro. Proc Natl Acad Sci USA 105: 11305-11310, 2008.
19. + exchange. Cardiovasc Res 69: 916-924, 2006.
20. Hodis HN, Kramsch DM, Avogaro P, Bittolo-Bon G, Cazzolato G, Hwang J, Peterson H, Sevanian A. Biochemical and cytotoxic characteristics of an in vivo circulating oxidized low density lipoprotein (LDL-). J Lipid Res 35: 669-677, 1994. (Pubitemid 24113109)
21. Holvoet P, Theilmeier G, Shivalkar B, Flameng W, Collen D. LDL hypercholesterolemia is associated with accumulation of oxidized LDL, atherosclerotic plaque growth, and compensatory vessel enlargement in coronary arteries of miniature pigs. Arterioscler Thromb Vasc Biol 18: 415-422, 1998. (Pubitemid 28125636)
22. Ingber DE. mechanical signaling and the cellular response to extracellular matrix in angiogenesis and cardiovascular physiology. Circ Res 91: 877-887, 2002.
23. Jialal I, Chait A. Differences in the metabolism of oxidatively modified low density lipoprotein and acetylated low density lipoprotein by human endothelial cells: inhibition of cholesterol esterification by oxidatively modified low density lipoprotein. J Lipid Res 30: 1561-1568, 1989. (Pubitemid 19271052)
24. Kowalsky GB, Byfield FJ, Levitan I. oxLDL facilitates flow-induced realignment of aortic endothelial cells. Am J Physiol Cell Physiol 295: C332-C340, 2008. (Pubitemid 352755779)
25. Kwik J, Boyle S, Fooksman D, Margolis L, Sheetz MP, Edidin M. Membrane cholesterol, lateral mobility, and the phosphatidylinositol 4,5-bisphosphate- dependent organization of cell actin. Proc Natl Acad Sci USA 100: 13964-13969, 2003. (Pubitemid 37499174)
26. Levitan I, Christian AE, Tulenko TN, Rothblat GH. Membrane cholesterol content modulates activation of volume-regulated anion current (VRAC) in bovine endothelial cells. J Gen Physiol 115: 405-416, 2000. (Pubitemid 30196589)
27. Levitan I, Gooch KJ. Lipid rafts in membrane-cytoskeleton interactions and control of cellular biomechanics: actions of oxLDL. Antioxid Redox Signal 9: 1519-1534, 2007. (Pubitemid 47260439)
28. Maor I, Kaplan M, Hayek T, Vaya J, Hoffman A, Aviram M. Oxidized monocyte-derived macrophages in aortic atherosclerotic lesion from apolipoprotein E-deficient mice and from human carotid artery contain lipid peroxides and oxysterols. Biochem Biophys Res Commun 269: 775-780, 2000. (Pubitemid 30440376)
29. Massey JB, Pownall HJ. The polar nature of 7-ketocholesterol determines its location within membrane domains and the kinetics of membrane microsolubilization by apolipoprotein A-I. Biochemistry 44: 10423-10433, 2005.
30. Mathur AB, Collinsworth AM, Reichert WM, Kraus WE, Truskey GA. Endothelial, cardiac muscle and skeletal muscle exhibit different viscous and elastic properties as determined by atomic force microscopy. J Biomech 34: 1545-1553, 2001.
31. Mathur AB, Truskey GA, Reichert WM. Atomic force and total internal reflection fluorescence microscopy for the study of force transmission in endothelial cells. Biophys J 78: 1725-1735, 2000. (Pubitemid 30183571)
32. Murugesan G, Chisolm GM, Fox PL. Oxidized low density lipoprotein inhibits the migration of aortic endothelial cells in vitro. J Cell Biol 120: 1011-1019, 1993. (Pubitemid 23056306)
33. Needham D, Nunn RS. Elastic deformation and failure of lipid bilayer membranes containing cholesterol. Biophys J 58: 997-1009, 1990. (Pubitemid 20307868)
34. Oberleithner H, Riethmuller C, Ludwig T, Shahin V, Stock C, Schwab A, Hausberg M, Kusche K, Schillers H. Differential action of steroid hormones on human endothelium. J Cell Sci 119: 1926-1932, 2006.
35. Oberleithner H, Riethmuller C, Schillers H, MacGregor GA, de Wardener HE, Hausberg M. Plasma sodium stiffens vascular endothelium and reduces nitric oxide release. Proc Natl Acad Sci USA 104: 16281-16286, 2007. (Pubitemid 350099397)
36. Ohashi T, Ishii Y, Ishikawa Y, Matsumoto T, Sato M. Experimental and numerical analyses of local mechanical properties measured by atomic force microscopy for sheared endothelial cells. Biomed Mater Eng 12: 319-327, 2002. (Pubitemid 35285175)
37. Sieminski AL, Hebbel RP, Gooch KJ. The relative magnitudes of endothelial force generation and matrix stiffness modulate capillary morphogenesis in vitro. Exp Cell Res 297: 574-584, 2004.
38. Subbaiah PV, Billington SJ, Jost BH, Songer JG, Lange Y. Sphingomyelinase D, a novel probe for cellular sphingomyelin: effects on cholesterol homeostasis in human skin fibroblasts. J Lipid Res 44: 1574-1580, 2003.
39. Subbaiah PV, Sowa JM, Singh DK. Sphingolipids and cellular cholesterol homeostasis. Effect of ceramide on cholesterol trafficking and HMG CoA reductase activity. Arch Biochem Biophys 474: 32-38, 2008.
40. Sun M, Northup N, Marga F, Byfield FJ, Levitan I, Forgacs G. Cellular cholesterol effects on membrane-cytoskeleton adhesion. J Cell Sci 120: 2223-2231, 2007. (Pubitemid 47074126)
41. Titushkin I, Cho M. Modulation of cellular mechanics during osteogenic differentiation of human mesenchymal stem cells. Biophys J 93: 3693-3702, 2007. (Pubitemid 350190831)
42. Van Tits LJ, van Himbergen TM, Lemmers HL, de Graaf J, Stalenhoef AF. Proportion of oxidized LDL relative to plasma apolipoprotein B does not change during statin therapy in patients with heterozygous familial hypercholesterolemia. Atherosclerosis 185: 307-312, 2006. (Pubitemid 43306742)
43. Vernon RB, Sage EH. Contraction of fibrillar type I collagen by endothelial cells: a study in vitro. J Cell Biochem 60: 185-197, 1996. (Pubitemid 26069214)
44. Virmani R, Kolodgie FD, Burke AP, Finn AV, Gold HK, Tulenko TN, Wrenn SP, Narula J. Atherosclerotic plaque progression and vulnerability to rupture: angiogenesis as a source of intraplaque hemorrhage. Arterioscler Thromb Vasc Biol 25: 2054-2061, 2005. (Pubitemid 41416300)
45. Walton KA, Gugiu BG, Thomas M, Basseri RJ, Eliav DR, Salomon RG, Berliner JA. A role for neutral sphingomyelinase activation in the inhibition of LPS action by phospholipid oxidation products. J Lipid Res 47: 1967-1974, 2006.
46. Wang J, Megha, London E. Relationship between sterol/steroid structure and participation in ordered lipid domains (lipid rafts): implications for lipid raft structure and function. Biochemistry 43: 1010-1018, 2004. (Pubitemid 38141500)
47. Xu X, London E. The effect of sterol structure on membrane lipid domains reveals how cholesterol can induce lipid domain formation. Biochemistry 39: 843-849, 2000. (Pubitemid 30075310)
48. Yla-Herttuala S, Palinski W, Rosenfeld ME, Parthasarathy S, Carew TE, Butler S, Witztum JL, Steinberg D. Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man. J Clin Invest 84: 1086-1095, 1989. (Pubitemid 19247577)
49. Zidovetzki R, Levitan I. Use of cyclodextrins to manipulate plasma membrane cholesterol content: evidence, misconceptions and control strategies. Biochim Biophys Acta 1768: 1311-1324, 2007. (Pubitemid 46782714)